Literature DB >> 15657691

[Best's disease. Overview of pathology and its causes].

B Lorenz1, M N Preising.   

Abstract

Best's disease is a hereditary affection with reduced penetrance and juvenile onset. The fundus may be unremarkable or present various stages up to scarring of the macula. Histopathology of advanced stages discloses deposits of lipofuscin on Bruch's membrane, the innermost layer of which is the basal membrane of the retinal pigment epithelium (RPE). The deposits correlate with lipofuscin and melanofuscin granulae in the RPE. Photoreceptors correlating with the lesions have lost their outer segments and the RPE as well as the photoreceptors appear edematous. Loss of photoreceptor function does not necessarily follow progression of fundus appearance. Loss of function usually correlates with a reduced Arden ratio of the electro-oculogram even in the absence of funduscopic changes.Best's disease is caused by mutations in VMD2 (hBEST1). Bestrophin, the gene product of hBEST1, is a regulatory part of a Ca(2+) channel or a Ca(2+)-dependent Cl(-)channel. In this paper the relevant data on clinical and genetic pathology are summarized and evaluated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657691     DOI: 10.1007/s00347-004-1158-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  21 in total

1.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium.

Authors:  A D Marmorstein; L Y Marmorstein; M Rayborn; X Wang; J G Hollyfield; K Petrukhin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Heredodegeneration of the macula lutea; a study of the clinical and pathologic aspects.

Authors:  C B McFARLAND
Journal:  AMA Arch Ophthalmol       Date:  1955-02

3.  Prevention of retinal venous occlusion with special reference to ambulatory dicumarol therapy.

Authors:  B A KLIEN
Journal:  Am J Ophthalmol       Date:  1950-02       Impact factor: 5.258

4.  Identification of the gene responsible for Best macular dystrophy.

Authors:  K Petrukhin; M J Koisti; B Bakall; W Li; G Xie; T Marknell; O Sandgren; K Forsman; G Holmgren; S Andreasson; M Vujic; A A Bergen; V McGarty-Dugan; D Figueroa; C P Austin; M L Metzker; C T Caskey; C Wadelius
Journal:  Nat Genet       Date:  1998-07       Impact factor: 38.330

5.  [Fluorescent angiography in multiple vitelliform retinal cysts of the posterior ocular pole].

Authors:  A Denden; K E Littann
Journal:  Ophthalmologica       Date:  1973       Impact factor: 3.250

6.  Effects of hypoxia and hyperoxia on the human standing potential.

Authors:  M F Marmor; W J Donovan; D M Gaba
Journal:  Doc Ophthalmol       Date:  1985-10-15       Impact factor: 2.379

7.  Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease).

Authors:  A Marquardt; H Stöhr; L A Passmore; F Krämer; A Rivera; B H Weber
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

8.  A histopathologic study of Best's macular dystrophy.

Authors:  G T Frangieh; W R Green; S L Fine
Journal:  Arch Ophthalmol       Date:  1982-07

9.  Histopathology of Best's macular dystrophy.

Authors:  T A Weingeist; J L Kobrin; R C Watzke
Journal:  Arch Ophthalmol       Date:  1982-07

10.  Long-term evaluation of patients with Best's vitelliform dystrophy.

Authors:  C W Mohler; S L Fine
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

View more
  8 in total

Review 1.  [Genetic diseases of the retinal pigment epithelium].

Authors:  M N Preising; B Lorenz
Journal:  Ophthalmologe       Date:  2009-04       Impact factor: 1.059

2.  Canine multifocal retinopathy in the Australian Shepherd: a case report.

Authors:  Ingo Hoffmann; Karina E Guziewicz; Barbara Zangerl; Gustavo D Aguirre; Christian Y Mardin
Journal:  Vet Ophthalmol       Date:  2012-03-20       Impact factor: 1.644

3.  Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease.

Authors:  Karina E Guziewicz; Barbara Zangerl; Sarah J Lindauer; Robert F Mullins; Lynne S Sandmeyer; Bruce H Grahn; Edwin M Stone; Gregory M Acland; Gustavo D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

4.  Assessment of canine BEST1 variations identifies new mutations and establishes an independent bestrophinopathy model (cmr3).

Authors:  Barbara Zangerl; Kaisa Wickström; Julianna Slavik; Sarah J Lindauer; Saija Ahonen; Claude Schelling; Hannes Lohi; Karina E Guziewicz; Gustavo D Aguirre
Journal:  Mol Vis       Date:  2010-12-16       Impact factor: 2.367

5.  Bestrophin 1 gene analysis and associated clinical findings in a Chinese patient with Best vitelliform macular dystrophy.

Authors:  Ying Lin; Tao Li; Hongbin Gao; Yu Lian; Chuan Chen; Yi Zhu; Yonghao Li; Bingqian Liu; Wenli Zhou; Hongye Jiang; Xialin Liu; Xiujuan Zhao; Xiaoling Liang; Chenjin Jin; Xinhua Huang; Lin Lu
Journal:  Mol Med Rep       Date:  2017-08-04       Impact factor: 2.952

Review 6.  The genetics of inherited retinal disorders in dogs: implications for diagnosis and management.

Authors:  Anna Palanova
Journal:  Vet Med (Auckl)       Date:  2016-03-15

7.  Impaired Bestrophin Channel Activity in an iPSC-RPE Model of Best Vitelliform Macular Dystrophy (BVMD) from an Early Onset Patient Carrying the P77S Dominant Mutation.

Authors:  Arnau Navinés-Ferrer; Sheila Ruiz-Nogales; Rafael Navarro; Esther Pomares
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

Review 8.  The genetics of eye disorders in the dog.

Authors:  Cathryn S Mellersh
Journal:  Canine Genet Epidemiol       Date:  2014-04-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.